CYH Community Health Systems, Inc. Common Stock
O Community Health Systems, Inc. Common Stock Przegląd firmy z Wikipedii
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
Czytaj więcej
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.
On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.
Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.
History
Founding and early years (1985–2014)
E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.
The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.
In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.
In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.
In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.
In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.
In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.
On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.
It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.
Recent developments (2015–present)
On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.
In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.
After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.
On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.
In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.
In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.
In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.
On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.
On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.
On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.
In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.
On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.
On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.
In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.
In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.
Predatory liens practices
Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
CYH Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
CYH Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 13 grudnia 2012 | $0,2066 |
CYH Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 1 6,2%
- Kup 1 6,2%
- Trzymaj 6 37,5%
- Sprzedaj 7 43,8%
- Mocna sprzedaż 1 6,2%
12-miesięczny cel cenowy
7 analityków · 2026-08-13Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.19 | $-0.06 | -0.13% |
| 31 marca 2026 | $-0.48 | $-0.10 | -0.38% |
| 31 grudnia 2025 | $-0.01 | $-0.10 | 0.10% |
| 30 września 2025 | $1.27 | $-0.25 | 1.5% |
| 30 czerwca 2025 | $-0.05 | $-0.11 | 0.06% |
| 31 marca 2025 | $-0.03 | $-0.08 | 0.05% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CYH | $433M | 0.8 | -1.2% | 4.1% | -30.8% | — |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | — |
| ARDT | $1.26B | 9.2 | 6.0% | 2.1% | 11.2% | — |
| NUTX | $1.17B | 15.7 | 82.4% | 8.1% | 30.6% | 50.8% |
| USPH | — | 55.0 | 16.3% | 5.1% | 8.2% | 19.2% |
| JYNT | $123M | 45.9 | 5.2% | 5.3% | 16.3% | — |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Cost of Revenue | $1.86B | $1.95B | $1.99B | $1.98B | $2.04B | $1.96B | $2.15B | $2.35B | $2.67B | $3.01B | |
| Operating Expenses | $11.00B | $12.09B | $11.53B | $11.39B | $10.97B | $10.66B | $12.56B | $13.95B | $17.23B | $19.30B | |
| Operating Income | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $650M | $208M | $-1.88B | $-860M | |
| Interest Income | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $7M | $11M | $14M | |
| Pretax Income | $724M | $-283M | $207M | $349M | $499M | $422M | $-430M | $-715M | $-2.83B | $-1.72B | |
| Income Tax | $48M | $79M | $191M | $170M | $131M | $-185M | $160M | $-11M | $-449M | $-104M | |
| Net Income | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| EPS (Basic) | $3.81 | $-3.90 | $-1.02 | $0.35 | $1.82 | $4.43 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| EPS (Diluted) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| Shares (Basic) | 133,564,227 | 132,101,768 | 130,445,677 | 128,808,387 | 126,754,852 | 115,491,022 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| Shares (Diluted) | 135,012,240 | 132,101,768 | 130,445,677 | 130,060,319 | 130,597,410 | 116,544,561 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| EBITDA | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $1.26B | $908M | $-1.02B | $240M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $260M | $37M | $38M | $118M | $507M | $1.68B | $216M | $196M | $563M | $238M | |
| Receivables | $2.08B | $2.29B | $2.23B | $2.04B | $2.06B | $1.93B | $2.26B | $2.35B | $2.38B | $3.18B | |
| Other Current Assets | $381M | $358M | $275M | $235M | $269M | $338M | $358M | $400M | $462M | $568M | |
| Current Assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B | $3.43B | $3.55B | $4.07B | $4.67B | |
| PP&E (Net) | $4.50B | $4.78B | $5.21B | $5.37B | $5.55B | $5.32B | $5.61B | $6.14B | $7.05B | $8.15B | |
| PP&E (Gross) | $8.91B | $9.16B | $9.51B | $9.64B | $9.76B | $9.35B | $9.65B | $10.30B | $11.50B | $12.42B | |
| Accum. Depreciation | $4.41B | $4.38B | $4.30B | $4.27B | $4.20B | $4.03B | $4.04B | $4.16B | $4.45B | $4.27B | |
| Goodwill | $3.32B | $3.79B | $3.96B | $4.17B | $4.22B | $4.22B | $4.33B | $4.56B | $4.72B | $6.52B | |
| Intangibles | $7M | $15M | $20M | $2M | · | · | · | · | $10M | $14M | |
| Other Non-current Assets | $2.10B | $2.17B | $2.05B | $2.01B | $1.91B | $1.90B | $2.21B | $1.54B | $1.54B | $2.59B | |
| Total Assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Accounts Payable | $842M | $913M | $912M | $773M | $830M | $783M | $811M | $887M | $967M | $995M | |
| Accrued Liabilities | · | · | · | · | · | · | $1.13B | $1.09B | $1.13B | $1.23B | |
| Current Liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B | $2.81B | $2.28B | $2.39B | $2.36B | $2.89B | |
| Capital Leases | $537M | $535M | $563M | $605M | $535M | $524M | $487M | $84M | $287M | $302M | |
| Deferred Tax | $25M | $231M | $369M | $354M | $192M | $29M | $200M | $26M | $19M | $411M | |
| Other Non-current Liabilities | $891M | $828M | $739M | $644M | $827M | $1.60B | $894M | $1.01B | $1.36B | $1.57B | |
| Total Liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B | $17.25B | $16.82B | $17.61B | $19.66B | |
| Long-term Debt | $10.40B | $11.45B | $11.49B | $11.63B | $12.14B | $12.22B | $13.40B | $13.60B | $13.91B | $15.24B | |
| Total Debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B | $13.38B | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Retained Earnings | $-3.57B | $-4.08B | $-3.56B | $-3.43B | $-3.48B | $-3.71B | $-4.22B | $-3.54B | $-2.76B | $-299M | |
| AOCI | $-9M | $-10M | $-14M | $-21M | $-14M | $-13M | $-9M | $-10M | $-21M | $-62M | |
| Stockholders' Equity | $-1.39B | $-1.91B | $-1.39B | $-1.37B | $-1.37B | $-1.62B | $-2.22B | $-1.53B | $-767M | $1.61B | |
| Liabilities + Equity | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Shares Outstanding | 138,626,917 | 138,919,641 | 136,774,911 | 134,703,717 | 132,146,282 | 129,612,117 | 117,822,631 | 116,248,376 | 114,651,004 | 113,876,580 |
Przepływy pieniężne 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $426M | $486M | $505M | $534M | $540M | $558M | $608M | $700M | $861M | $1.10B | |
| Stock-based Comp | $11M | $17M | $22M | $20M | $25M | $13M | $10M | $13M | $24M | $46M | |
| Deferred Tax | $-243M | $-116M | $35M | $165M | $171M | $-187M | $203M | $-3M | $-454M | $-116M | |
| Restructuring | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $239M | $352M | $2.80B | $1.83B | |
| Operating Cash Flow | $543M | $480M | $210M | $300M | $-131M | $2.18B | $385M | $274M | $773M | $1.14B | |
| CapEx | $335M | $360M | $467M | $415M | $469M | $440M | $438M | $527M | $564M | $744M | |
| Investing Cash Flow | $847M | $-275M | $-26M | $-259M | $-524M | $177M | $-2M | $-245M | $1.07B | $630M | |
| Net Debt Issued | $-6.52B | $-5.06B | $-4.32B | $-2.36B | $-4.43B | $-5.49B | $-3.56B | $-2.03B | $-5.39B | $-6.71B | |
| Financing Cash Flow | $-1.17B | $-206M | $-264M | $-430M | $-514M | $-895M | $-363M | $-396M | $-1.52B | $-1.71B | |
| Net Change in Cash | $223M | $-1M | $-80M | $-389M | $-1.17B | $1.46B | $20M | $-367M | $325M | $54M | |
| Taxes Paid | $249M | $171M | $91M | $-6M | $-4M | $-2M | $3M | $19M | $-4M | $16M | |
| Free Cash Flow | $208M | $120M | $-257M | $-115M | $-600M | $1.74B | $-53M | $-253M | $209M | $393M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 4.9% | 1.5% | · | · | |
| Net Margin | 4.1% | -4.1% | -1.1% | 0.38% | 1.9% | 4.3% | -5.1% | -5.6% | · | · | |
| Pretax Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | 3.6% | -3.3% | -5.1% | · | · | |
| EBITDA Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 9.5% | 6.4% | · | · | |
| ROA | 3.7% | -3.6% | -0.91% | 0.31% | 1.5% | 3.2% | -4.3% | -4.7% | -12.5% | -7.1% | |
| ROE | -30.8% | 31.2% | 9.6% | -3.4% | -15.3% | -26.6% | 36.0% | 68.5% | -580.0% | -61.1% | |
| ROIC | 15.5% | 7.3% | 0.73% | 4.1% | 9.6% | 15.5% | 8.0% | -13.3% | 206.0% | -50.0% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 | 1.6 | 1.5 | 1.5 | 1.7 | 1.6 | |
| Quick Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 1.1 | 1.3 | 1.2 | |
| Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · | |
| LT Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | |
| Receivables Turnover | 5.7 | 5.6 | 5.8 | 6.0 | 6.2 | 5.6 | 5.7 | 6.0 | · | · |
Stopy Wzrostu 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.2% | 1.1% | 2.3% | -1.3% | 4.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.74% | 0.71% | 1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -80.1% | -59.9% | · | · | · | · | · | |
| EPS CAGR 3Y | 120.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -80.0% | -55.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 122.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.08% | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Net Income TTM | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| Market Cap | $433M | $415M | $428M | $582M | $1.76B | $963M | $342M | $328M | $488M | $637M | |
| Enterprise Value | $10.55B | $11.81B | $11.86B | $12.08B | $13.36B | $11.38B | $13.51B | · | · | · | |
| P/E | 0.8 | -0.8 | -3.1 | 12.3 | 7.6 | 1.7 | -0.5 | -0.4 | -0.2 | -0.4 | |
| P/S | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| P/B | -0.3 | -0.2 | -0.3 | -0.4 | -1.3 | -0.6 | -0.2 | -0.2 | -0.6 | 0.4 | |
| P / Cash Flow | 0.8 | 0.9 | 2.0 | 1.9 | -13.4 | 0.4 | 0.9 | 1.2 | 0.6 | 0.6 | |
| P / FCF | 2.1 | 3.5 | -1.7 | -5.1 | -2.9 | 0.6 | -6.4 | -1.3 | 2.3 | 1.6 | |
| EV / EBITDA | 7.1 | 21.8 | 12.4 | 14.7 | 9.5 | 10.1 | 10.7 | · | · | · | |
| EV / FCF | 50.7 | 98.4 | -46.1 | -105.0 | -22.3 | 6.5 | -254.9 | · | · | · | |
| EV / Revenue | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | · | · | · | |
| Earnings Yield | 120.8% | -130.4% | -32.6% | 8.1% | 13.2% | 59.1% | -204.5% | -247.9% | -516.4% | -278.0% |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.26B | $3.09B | $3.14B | $3.14B | $3.18B | $3.09B | $3.12B | $3.11B | $3.14B | $3.02B | |
| Cost of Revenue | $401M | $441M | $446M | $460M | $469M | $489M | $507M | $469M | $483M | $487M | $493M | $489M | $504M | $507M | $497M | $492M | |
| Operating Expenses | $2.44B | $2.68B | $2.66B | $2.84B | $2.62B | $2.88B | $2.99B | $3.29B | $2.90B | $2.91B | $2.85B | $2.91B | $2.87B | $2.90B | $2.91B | $2.82B | |
| Operating Income | $389M | $281M | $449M | $243M | $512M | $284M | $278M | $-205M | $238M | $231M | $328M | $173M | $246M | $210M | $228M | $204M | |
| Interest Income | $1M | $1M | $0 | $1M | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | |
| Pretax Income | $180M | $64M | $221M | $-2M | $438M | $67M | $64M | $-419M | $50M | $22M | $194M | $-33M | $40M | $6M | $324M | $70M | |
| Income Tax | $76M | $89M | $61M | $-173M | $118M | $42M | $91M | $-64M | $24M | $28M | $108M | $19M | $38M | $26M | $-123M | $70M | |
| Net Income | $70M | $-58M | $110M | $130M | $282M | $-13M | $-71M | $-391M | $-13M | $-41M | $47M | $-91M | $-38M | $-51M | $415M | $-42M | |
| EPS (Basic) | $0.51 | $-0.43 | $0.83 | $0.97 | $2.11 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| EPS (Diluted) | $0.51 | $-0.43 | $0.82 | $0.96 | $2.09 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| Shares (Basic) | 135,494,789 | 134,417,158 | -266,863,732 | 133,787,535 | 133,763,733 | 132,876,691 | -263,891,006 | 132,376,226 | 132,344,504 | 131,272,044 | -260,601,819 | 130,698,907 | 130,659,672 | 129,688,917 | -257,247,066 | 129,141,673 | |
| Shares (Diluted) | 136,505,102 | 134,417,158 | -267,935,024 | 135,187,592 | 134,882,981 | 132,876,691 | -263,891,006 | 132,376,226 | 132,344,504 | 131,272,044 | -260,601,819 | 130,698,907 | 130,659,672 | 129,688,917 | -255,995,134 | 129,141,673 | |
| EBITDA | $389M | $281M | · | $243M | $512M | $284M | · | $-205M | $238M | $231M | · | $173M | $246M | $210M | · | $204M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $149M | $712M | $260M | $123M | $456M | $431M | $37M | $33M | $39M | $48M | · | $91M | $118M | $144M | · | $300M | |
| Receivables | $2.14B | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B | $2.04B | $2.19B | $2.19B | · | $2.16B | $2.04B | $2.04B | · | $1.97B | |
| Other Current Assets | $308M | $421M | $381M | $325M | $351M | $61M | $358M | $402M | $292M | $307M | · | $325M | $339M | $227M | · | $301M | |
| Current Assets | $3.08B | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B | $3.11B | $3.20B | $3.17B | · | $3.25B | $3.19B | $3.11B | · | $3.27B | |
| PP&E (Net) | $4.18B | $4.20B | $4.50B | $4.62B | $4.66B | $4.74B | $4.78B | $4.96B | $5.22B | $5.22B | · | $5.16B | $5.25B | $5.25B | · | $5.45B | |
| PP&E (Gross) | $8.04B | $8.09B | $8.91B | $9.06B | $9.02B | $9.20B | $9.16B | $9.09B | $9.59B | $9.61B | · | $9.37B | $9.53B | $9.56B | · | $9.73B | |
| Accum. Depreciation | $3.86B | $3.89B | $4.41B | $4.44B | $4.37B | $4.46B | $4.38B | $4.13B | $4.37B | $4.39B | · | $4.21B | $4.28B | $4.30B | · | $4.28B | |
| Goodwill | $3.23B | $3.13B | $3.32B | $3.54B | $3.60B | $3.79B | $3.79B | $3.94B | $3.97B | $3.96B | $3.96B | $3.94B | $4.05B | $4.05B | $4.17B | $4.20B | |
| Intangibles | · | · | $7M | · | · | · | $15M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.65B | $2.05B | $2.10B | $1.81B | $1.71B | $1.94B | $2.17B | $1.86B | $1.99B | $2.04B | · | $2.27B | $2.10B | $2.15B | · | $1.94B | |
| Total Assets | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Accounts Payable | $713M | $790M | $842M | $894M | $970M | $974M | $913M | $842M | $896M | $941M | · | $837M | $736M | $712M | · | $820M | |
| Current Liabilities | $2.02B | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B | $2.13B | $2.17B | $2.14B | · | $2.15B | $2.08B | $2.13B | · | $2.38B | |
| Capital Leases | $527M | $504M | $537M | $527M | $514M | $535M | $535M | $528M | $542M | $546M | · | $560M | $580M | $588M | · | $563M | |
| Deferred Tax | $25M | $25M | $25M | $30M | $240M | $205M | $231M | $239M | $351M | $354M | · | $344M | $362M | $351M | · | $477M | |
| Other Non-current Liabilities | $901M | $922M | $891M | $866M | $850M | $806M | $828M | $815M | $721M | $726M | · | $694M | $722M | $647M | · | $726M | |
| Total Liabilities | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | · | $15.57B | $15.47B | $15.41B | · | $16.09B | |
| Long-term Debt | · | · | $10.40B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $9.55B | $10.13B | · | $10.59B | $10.84B | $11.30B | · | $11.47B | $11.50B | $11.53B | · | $11.82B | $11.73B | $11.70B | · | $11.94B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $-3.56B | $-3.63B | $-3.57B | $-3.68B | $-3.81B | $-4.09B | $-4.08B | $-4.01B | $-3.62B | $-3.60B | · | $-3.61B | $-3.52B | $-3.48B | · | $-3.85B | |
| AOCI | $-11M | $-10M | $-9M | $-5M | $-5M | $-7M | $-10M | $-8M | $-13M | $-16M | · | $-23M | $-19M | $-18M | $-21M | $-33M | |
| Stockholders' Equity | $-1.39B | $-1.45B | $-1.39B | $-1.50B | $-1.63B | $-1.92B | $-1.91B | $-1.82B | $-1.44B | $-1.43B | · | $-1.46B | $-1.49B | $-1.45B | · | $-1.79B | |
| Liabilities + Equity | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Shares Outstanding | 141,010,284 | 140,916,712 | 138,626,917 | 140,119,616 | 140,119,616 | 140,302,924 | 138,919,641 | 138,936,058 | 138,960,194 | 138,966,388 | · | 136,772,094 | 136,802,806 | 136,749,427 | · | 134,698,067 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $108M | $114M | $108M | $108M | $105M | $105M | $129M | $117M | $125M | $115M | $121M | $128M | $124M | $132M | $136M | $137M | |
| Stock-based Comp | $2M | $3M | $5M | $-1M | $3M | $4M | $5M | $4M | $2M | $6M | $6M | $6M | $4M | $6M | $6M | $6M | |
| Operating Cash Flow | $88M | $-297M | $266M | $69M | $88M | $120M | $216M | $67M | $101M | $96M | $90M | $29M | $86M | $5M | $9M | $137M | |
| CapEx | $76M | $76M | $94M | $65M | $91M | $85M | $109M | $70M | $88M | $93M | $110M | $130M | $105M | $122M | $131M | $93M | |
| Investing Cash Flow | $-23M | $1.02B | $142M | $-81M | $342M | $444M | $-143M | $75M | $-108M | $-99M | $180M | $-101M | $-86M | $-19M | $-52M | $30M | |
| Net Debt Issued | · | $-351M | · | · | · | $-1.09B | · | · | · | $-885M | · | · | · | $-757M | · | · | |
| Financing Cash Flow | $-628M | $-274M | $-271M | $-321M | $-405M | $-170M | $-69M | $-148M | $-2M | $13M | $-323M | $45M | $-26M | $40M | $-139M | $-213M | |
| Net Change in Cash | $-563M | $452M | $137M | $-333M | $25M | $394M | $4M | $-6M | $-9M | $10M | $-53M | · | · | $26M | $-182M | $-46M | |
| Taxes Paid | $61M | $0 | $441M | $-91M | $181M | $80M | $303M | $-48M | $-84M | $0 | $152M | $-24M | $-37M | · | $0 | $0 | |
| Free Cash Flow | · | $-373M | · | · | · | $35M | · | · | · | $3M | · | · | · | $-117M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| Net Margin | 2.5% | -2.0% | · | 4.2% | 9.0% | -0.41% | · | -12.7% | -0.41% | -1.3% | · | -2.9% | -1.2% | -1.6% | · | -1.4% | |
| Pretax Margin | 6.4% | 2.2% | · | -0.06% | 14.0% | 2.1% | · | -13.6% | 1.6% | 0.70% | · | -1.1% | 1.3% | 0.19% | · | 2.3% | |
| EBITDA Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| ROA | 0.54% | -0.43% | · | 0.96% | 2.0% | -0.09% | · | -2.7% | -0.09% | -0.28% | · | -0.62% | -0.26% | -0.34% | · | -0.27% | |
| ROE | -4.6% | 3.4% | · | -7.8% | -18.4% | 0.78% | · | 23.8% | 0.89% | 2.9% | · | 5.6% | 2.4% | 3.6% | · | 2.5% | |
| ROIC | 2.8% | -1.3% | · | -228.6% | 4.1% | 1.1% | · | -1.8% | 1.2% | -0.62% | · | 2.6% | 0.12% | -6.8% | · | 0.00% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.5 | 1.6 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.2 | 1.2 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 | |
| LT Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.5 |
Wycena (TTM) 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.01B | $12.34B | · | $12.47B | $12.52B | $12.53B | · | $12.46B | $12.48B | $12.45B | · | $12.33B | $12.18B | $12.18B | · | $12.19B | |
| Net Income TTM | $424M | $341M | · | $8M | $-135M | $-458M | · | $-536M | $-183M | $-221M | · | $-222M | $-457M | $-420M | · | $-258M | |
| Market Cap | $471M | $414M | · | $450M | $476M | $379M | · | $843M | $467M | $486M | · | $397M | $602M | $670M | · | $290M | |
| Enterprise Value | $9.87B | $9.83B | · | $10.92B | $10.86B | $11.25B | · | $12.28B | $11.93B | $11.97B | · | $12.13B | $12.21B | $12.22B | · | $11.93B | |
| P/E | 1.1 | 1.2 | · | · | -3.2 | -0.8 | · | -1.5 | -2.4 | -2.1 | · | -1.7 | -1.2 | -1.5 | · | -1.1 | |
| P/S | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| P/B | -0.3 | -0.3 | · | -0.3 | -0.3 | -0.2 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -0.5 | · | -0.2 | |
| P / Cash Flow | · | -1.4 | · | · | · | 3.2 | · | · | · | 5.1 | · | · | · | 134.0 | · | · | |
| P / FCF | · | -1.1 | · | · | · | 10.8 | · | · | · | 162.1 | · | · | · | -5.7 | · | · | |
| EV / EBITDA | 25.4 | 35.0 | · | 44.9 | 21.2 | 39.6 | · | -59.9 | 50.1 | 51.8 | · | 70.1 | 49.6 | 58.2 | · | 58.5 | |
| EV / FCF | · | -26.4 | · | · | · | 321.5 | · | · | · | 3990.5 | · | · | · | -104.5 | · | · | |
| EV / Revenue | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Earnings Yield | 93.7% | 85.7% | · | 0.00% | -31.2% | -128.5% | · | -66.9% | -41.7% | -48.6% | · | -58.6% | -80.2% | -66.3% | · | -93.0% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B |
| Marża Operacyjna % | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% |
| Zysk netto | $509M | $-516M | $-133M | $46M | $230M |
| Rozwodniony EPS | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 |
| Wskaźnik bieżący | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 |
| Wskaźnik Szybkości | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $208M | $120M | $-257M | $-115M | $-600M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 201 emitentów · $341.1M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 37 (+19 vs poprzedni kw.) | 24 (+4 vs poprzedni kw.) | 65 (+4 vs poprzedni kw.) | 49 (-12 vs poprzedni kw.) | +15.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| CastleKnight Management LP | $44 704 517 | 13 384 586 | 13,10% | Akcje |
| Apollo Management Holdings, L.P. | $39 610 817 | 11 859 526 | 11,61% | Akcje |
| Eversept Partners, LP | $26 267 680 | 7 864 575 | 7,70% | Akcje |
| VANGUARD GROUP INC | $25 789 362 | 8 265 821 | 7,56% | Akcje |
| NOMURA HOLDINGS INC | $22 388 384 | 6 703 109 | 6,56% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $17 668 370 | 5 289 931 | 5,18% | Akcje |
| WHITEBOX ADVISORS LLC | $12 467 362 | 3 732 743 | 3,65% | Akcje |
| STATE STREET CORP | $10 226 622 | 3 061 863 | 3,00% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10 082 117 | 3 018 598 | 2,96% | Akcje |
| Saba Capital Management, L.P. | $9 626 444 | 2 882 169 | 2,82% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $9 084 165 | 2 719 143 | 2,66% | Akcje |
| Owl Creek Asset Management, L.P. | $8 452 277 | 2 530 622 | 2,48% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8 176 380 | 2 448 018 | 2,40% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $7 510 531 | 2 248 662 | 2,20% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $7 365 822 | 2 205 336 | 2,16% | Akcje |
| Diameter Capital Partners LP | $6 138 793 | 1 837 962 | 1,80% | Akcje |
| TWO SIGMA ADVISERS, LP | $5 816 476 | 1 864 255 | 1,70% | Akcje |
| CARRONADE CAPITAL MANAGEMENT, LP | $5 230 000 | 1 565 847 | 1,53% | Akcje |
| Allianz Asset Management GmbH | $5 167 919 | 1 547 281 | 1,51% | Akcje |
| D. E. Shaw & Co., Inc. | $4 779 143 | 1 430 881 | 1,40% | Akcje |
| Silver Rock Financial LP | $3 674 000 | 1 100 000 | 1,08% | Akcje |
| CITADEL ADVISORS LLC | $3 177 085 | 951 223 | 0,93% | Akcje |
| Assenagon Asset Management S.A. | $2 788 275 | 834 813 | 0,82% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 642 231 | 791 087 | 0,77% | Akcje |
| BANK OF AMERICA CORP /DE/ | $2 566 736 | 768 484 | 0,75% | Akcje |
| Jefferies Financial Group Inc. | $2 481 286 | 742 900 | 0,73% | Akcje |
| Alta Fundamental Advisers LLC | $2 161 411 | 647 129 | 0,63% | Akcje |
| GOLDMAN SACHS GROUP INC | $2 016 194 | 603 651 | 0,59% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $1 701 580 | 509 455 | 0,50% | Akcje |
| ExodusPoint Capital Management, LP | $1 664 603 | 498 384 | 0,49% | Akcje |
| READYSTATE ASSET MANAGEMENT LP | $1 657 729 | 496 326 | 0,49% | Akcje |
| WOLVERINE ASSET MANAGEMENT LLC | $1 339 674 | 401 100 | 0,39% | Opcja kupna |
| Helix Partners Management LP | $1 336 000 | 400 000 | 0,39% | Akcje |
| Bank of New York Mellon Corp | $1 325 679 | 396 910 | 0,39% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $1 280 940 | 383 515 | 0,38% | Akcje |
| Voleon Capital Management LP | $1 247 032 | 373 363 | 0,37% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $999 388 | 299 218 | 0,29% | Akcje |
| Pathstone Holdings, LLC | $895 621 | 268 150 | 0,26% | Akcje |
| Prescott Group Capital Management, L.L.C. | $863 076 | 258 406 | 0,25% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $835 000 | 250 000 | 0,24% | Opcja sprzedaży |
| FEDERATED HERMES, INC. | $812 599 | 243 293 | 0,24% | Akcje |
| LPL Financial LLC | $737 239 | 220 730 | 0,22% | Akcje |
| IEQ CAPITAL, LLC | $657 963 | 196 995 | 0,19% | Akcje |
| RHUMBLINE ADVISERS | $543 412 | 162 701 | 0,16% | Akcje |
| Nuveen, LLC | $535 683 | 160 384 | 0,16% | Akcje |
| BOOTHBAY FUND MANAGEMENT, LLC | $506 701 | 151 707 | 0,15% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $501 668 | 150 200 | 0,15% | Opcja kupna |
| Caption Management, LLC | $501 000 | 150 000 | 0,15% | Opcja kupna |
| Nuveen Asset Management, LLC | $479 548 | 160 384 | 0,14% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $442 056 | 132 352 | 0,13% | Akcje |
| DEUTSCHE BANK AG\ | $423 131 | 126 686 | 0,12% | Akcje |
| State of Wyoming | $386 675 | 115 771 | 0,11% | Akcje |
| CAHABA WEALTH MANAGEMENT, INC. | $367 400 | 110 000 | 0,11% | Akcje |
| STRS OHIO | $334 000 | 100 000 | 0,10% | Akcje |
| EQUITABLE TRUST CO | $334 000 | 100 000 | 0,10% | Akcje |
| Turtle Creek Wealth Advisors, LLC | $334 000 | 100 000 | 0,10% | Akcje |
| Parkwoods Wealth Partners, LLC | $330 319 | 98 898 | 0,10% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $322 096 | 96 436 | 0,09% | Akcje |
| CITIGROUP INC | $321 361 | 96 216 | 0,09% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $311 640 | 106 000 | 0,09% | Akcje |
| Lombard Odier Asset Management (USA) Corp | $297 260 | 89 000 | 0,09% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $287 908 | 86 200 | 0,08% | Opcja sprzedaży |
| NorthCrest Asset Manangement, LLC | $283 320 | 76 573 | 0,08% | Akcje |
| MetLife Investment Management, LLC | $278 232 | 83 303 | 0,08% | Akcje |
| CITADEL ADVISORS LLC | $242 818 | 72 700 | 0,07% | Opcja sprzedaży |
| LAZARD ASSET MANAGEMENT LLC | $240 887 | 72 122 | 0,07% | Akcje |
| Cetera Investment Advisers | $223 339 | 66 868 | 0,07% | Akcje |
| Mariner, LLC | $222 538 | 66 627 | 0,07% | Akcje |
| Cerity Partners LLC | $211 102 | 63 204 | 0,06% | Akcje |
| Apollon Wealth Management, LLC | $203 453 | 60 914 | 0,06% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $199 755 | 59 807 | 0,06% | Akcje |
| JANE STREET GROUP, LLC | $179 692 | 53 800 | 0,05% | Opcja kupna |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $176 339 | 128 756 | 0,05% | Akcje |
| Invesco Ltd. | $171 559 | 51 365 | 0,05% | Akcje |
| CITADEL ADVISORS LLC | $153 640 | 46 000 | 0,05% | Opcja kupna |
| MERCER GLOBAL ADVISORS INC /ADV | $150 911 | 45 183 | 0,04% | Akcje |
| Schonfeld Strategic Advisors LLC | $147 660 | 44 210 | 0,04% | Akcje |
| Vanguard Global Advisers, LLC | $144 134 | 43 154 | 0,04% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $136 659 | 40 916 | 0,04% | Akcje |
| Red Door Wealth Management, LLC | $130 260 | 39 000 | 0,04% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $128 810 | 38 566 | 0,04% | Akcje |
| BlackRock, Inc. | $126 606 | 37 906 | 0,04% | Akcje |
| XTX Topco Ltd | $126 098 | 37 754 | 0,04% | Akcje |
| GROUP ONE TRADING LLC | $123 633 | 37 016 | 0,04% | Akcje |
| Bison Wealth, LLC | $121 992 | 33 150 | 0,04% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $116 957 | 35 017 | 0,03% | Akcje |
| Nebula Research & Development LLC | $116 025 | 34 125 | 0,03% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $113 724 | 34 049 | 0,03% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $111 419 | 33 359 | 0,03% | Akcje |
| Quantbot Technologies LP | $110 450 | 33 069 | 0,03% | Akcje |
| WOLVERINE TRADING, LLC | $108 016 | 34 400 | 0,03% | Opcja kupna |
| INTECH INVESTMENT MANAGEMENT LLC | $107 535 | 32 196 | 0,03% | Akcje |
| Advisory Services Network, LLC | $105 845 | 31 690 | 0,03% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $105 537 | 31 598 | 0,03% | Akcje |
| Independent Advisor Alliance | $99 766 | 29 870 | 0,03% | Akcje |
| Callan Family Office, LLC | $96 195 | 28 801 | 0,03% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $91 736 | 27 466 | 0,03% | Akcje |
| Brevan Howard Capital Management LP | $91 125 | 27 283 | 0,03% | Akcje |
| Atom Investors LP | $90 527 | 27 104 | 0,03% | Akcje |
| Lakeview Capital Partners, LLC | $89 580 | 29 960 | 0,03% | Akcje |
Insiderzy spółki 57 insiderów · 29 dyrektorzy generalni · 23 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kevin J Hammons | CEO | 1 marca 2026 A | 895 545 | 0 | 0 | $0 |
| Tim Hingtgen | CEO | 1 marca 2025 A | 1 388 781 | 0 | 0 | $0 |
| Jason K Johnson | EVP & CFO | 1 marca 2026 A | 268 439 | 0 | 0 | $0 |
| Thomas J Aaron | EVP and CFO | 7 grudnia 2019 F | 241 515 | 0 | 0 | $0 |
| Larry W Cash | President and CFO | 1 marca 2017 A | 568 152 | 0 | 0 | $0 |
| Miguel S Benet | President and CMO | 1 marca 2025 D | 47 635 | 0 | 0 | $0 |
| Austen D Mason | Regional President | 1 marca 2025 A | 142 500 | 0 | 0 | $0 |
| Mark B Medley | Regional President | 1 marca 2025 A | 128 637 | 0 | 0 | $0 |
| Chad A Campbell | Regional President | 1 marca 2025 A | 136 815 | 0 | 0 | $0 |
| Charles J Cova | Regional President | 1 marca 2024 A | 58 701 | 0 | 0 | $0 |
| Lynn T Simon | President and CMO | 1 marca 2024 A | 482 657 | 0 | 0 | $0 |
| Beryl Ramsey | Division President | 1 marca 2019 A | 62 969 | 0 | 0 | $0 |
| Patton Paul Smith | Division President | 1 marca 2019 F | 119 017 | 0 | 0 | $0 |
| Iii John W Mcclellan | Division President | 1 marca 2017 A | 41 242 | 0 | 0 | $0 |
| Robert O Horrar | Division President | 1 marca 2017 A | 68 649 | 0 | 0 | $0 |
| Martin Bonick | Division President | 1 marca 2017 A | 100 458 | 0 | 0 | $0 |
| Michael T Portacci | Division President | 1 marca 2017 A | 110 156 | 0 | 0 | $0 |
| Thomas Daniel Miller | Division President | 1 marca 2016 A | 112 107 | 0 | 0 | $0 |
| David Lewis Miller | President and COO | 1 marca 2016 A | 440 840 | 0 | 0 | $0 |
| William S Hussey | Division President | 28 października 2015 M | 121 568 | 0 | 0 | $0 |
| Martin Dewayne Smith | Division President | 3 czerwca 2015 M | 94 111 | 0 | 0 | $0 |
| Gary D Newsome | Division President - Group Ops | 25 sierpnia 2008 M | 118 286 | 0 | 0 | $0 |
| David V. Rice | EVP-Clinical Operations & CMO | 1 czerwca 2026 A | 30 000 | 0 | 0 | $0 |
| Phillip A. Posey | SVP & CAO | 1 marca 2026 A | 51 736 | 0 | 0 | $0 |
| Justin D Pitt | Pres,Chief Legal&Admin Officer | 1 marca 2026 A | 287 750 | 0 | 0 | $0 |
| Kevin A Stockton | EVP, Operations & Development | 1 marca 2026 A | 208 290 | 0 | 0 | $0 |
| Rachel A Seifert | Executive VP and Secretary | 1 marca 2017 F | 243 065 | 0 | 0 | $0 |
| Mark T Buford | SVP/Chief Accounting Officer | 25 lutego 2012 F | 78 379 | 0 | 0 | $0 |
| Martin G Schweinhart | Senior Vice President | 1 marca 2006 A | 40 354 | 0 | 0 | $0 |
| Ranga K Krishnan | Dyrektor | 30 czerwca 2026 M | 170 023 | 0 | 0 | $0 |
| Fawn D Lopez | Dyrektor | 1 marca 2026 A | — | 0 | 0 | $0 |
| Ronald L Burgess JR | Dyrektor | 1 marca 2026 A | — | 0 | 0 | $0 |
| Susan W Brooks | Dyrektor | 1 marca 2026 A | 108 695 | 0 | 0 | $0 |
| Hubert James Williams | Dyrektor | 1 marca 2026 A | 211 863 | 0 | 0 | $0 |
| Joseph Arthur Hastings | Dyrektor | 1 marca 2026 A | 0 | 0 | 0 | $0 |
| Elizabeth T Hirsch | Dyrektor | 1 marca 2026 A | 162 059 | 0 | 0 | $0 |
| James S. Ely III | Dyrektor | 1 marca 2026 A | 412 876 | 0 | 0 | $0 |
| William Norris Jennings | Dyrektor | 1 marca 2026 A | 78 468 | 0 | 0 | $0 |
| John A Fry | Dyrektor | 1 marca 2026 A | 268 966 | 0 | 0 | $0 |
| John A Clerico | Dyrektor | 1 marca 2026 A | 368 763 | 0 | 0 | $0 |
| Michael Dinkins | Dyrektor | 1 marca 2026 A | 225 882 | 0 | 0 | $0 |
| Wayne T Smith | Dyrektor | 1 marca 2026 A | 5 217 579 | 0 | 0 | $0 |
| Julia B North | Dyrektor | 1 marca 2021 A | 162 056 | 0 | 0 | $0 |
| Mitchell H Watson JR | Dyrektor | 16 maja 2017 M | 22 594 | 0 | 0 | $0 |
| Harvey Klein MD | Dyrektor | 15 marca 2010 M | 10 383 | 0 | 0 | $0 |
| Dale F Frey | Dyrektor | 31 marca 2008 A | 20 000 | 0 | 0 | $0 |
| Thomas H Lister | Dyrektor | 21 września 2004 S | 0 | 0 | 0 | $0 |
| Thodore Forstmann | Dyrektor | 21 września 2004 S | 0 | 0 | 0 | $0 |
| Sandra Horbach | Dyrektor | 21 września 2004 S | 0 | 0 | 0 | $0 |
| Robert J Dole | Dyrektor | 6 maja 2004 S | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 zgłoszenia | 11 marca 2021 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 36 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| BSJR · Invesco Exchange-Traded Self-Indexe… | 2,68% | 21 287 000 | 8 sierpnia 2026 | Dziennie |
| EBIT · Harbor ETF Trust | 0,48% | 19 323 NS | 30 kwietnia 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,35% | 1 058 000 PA | 8 sierpnia 2026 | Dziennie |
| DFVE · DoubleLine ETF Trust | 0,20% | 18 550 NS | 31 marca 2026 | N-PORT |
| IWC · iShares Trust | 0,09% | 441 586 SH | 8 sierpnia 2026 | Dziennie |
| IHF · iShares Trust | 0,06% | 232 511 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 132 595 NS | 31 maja 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 113 109 SH | 8 sierpnia 2026 | Dziennie |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1 304 000 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 253 747 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,02% | 1 218 442 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 3 418 265 SH | 8 sierpnia 2026 | Dziennie |
| FNDX · SCHWAB STRATEGIC TRUST | 0,01% | 1 126 552 NS | 31 maja 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 56 434 NS | 30 kwietnia 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 53 684 NS | 31 maja 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 746 733 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 349 881 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 466 961 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 6 034 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 546 576 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 4 719 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 4 772 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 5 006 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 120 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 202 789 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 33 838 NS | 30 kwietnia 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 203 866 SH | 8 sierpnia 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 41 727 SH | 8 sierpnia 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,00% | 6 184 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 31 135 NS | 30 kwietnia 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 70 316 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1 347 195 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 813 888 SH | 8 sierpnia 2026 | Dziennie |
| VPLS · VANGUARD MALVERN FUNDS | 0,00% | 20 000 PA | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 817 SH | 8 sierpnia 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,00% | 24 NS | 30 kwietnia 2026 | N-PORT |